Journal article
Interaction between genes and macronutrient intake on the risk of developing type 2 diabetes: systematic review and findings from European Prospective Investigation into Cancer (EPIC)-InterAct.
- Abstract:
-
Background
Gene-diet interactions have been reported to contribute to the development of type 2 diabetes (T2D). However, to our knowledge, few examples have been consistently replicated to date.
Objective
We aimed to identify existing evidence for genemacronutrient interactions and T2D and to examine the reported interactions in a large-scale study.
Design
We systematically reviewed studies reporting genemacronutrient interactions and T2D. We searched the MEDLINE, Human Genome Epidemiology Network, and WHO International Clinical Trials Registry Platform electronic databases to identify studies published up to October 2015. Eligibility criteria included assessment of macronutrient quantity (e.g., total carbohydrate) or indicators of quality (e.g., dietary fiber) by use of self-report or objective biomarkers of intake. Interactions identified in the review were subsequently examined in the EPIC (European Prospective Investigation into Cancer)-InterAct case-cohort study (n = 21,148, with 9403 T2D cases; 8 European countries). Prentice-weighted Cox regression was used to estimate countryspecific HRs, 95% CIs, and P-interaction values, which were then pooled by random-effects meta-analysis. A primary model was fitted by using the same covariates as reported in the published studies, and a second model adjusted for additional covariates and estimated the effects of isocaloric macronutrient substitution.
Results
Thirteen observational studies met the eligibility criteria (n , 1700 cases). Eight unique interactions were reported to be significant between macronutrients [carbohydrate, fat, saturated fat, dietary fiber, and glycemic load derived from self-report of dietary intake and circulating n–3 (v-3) polyunsaturated fatty acids] and genetic variants in or near transcription factor 7–like 2 (TCF7L2), gastric inhibitory polypeptide receptor (GIPR), caveolin 2 (CAV2), and peptidase D (PEPD) (P-interaction , 0.05). We found no evidence of interaction when we tried to replicate previously reported interactions. In addition, no interactions were detected in models with additional covariates.
Conclusions
Eight gene-macronutrient interactions were identified for the risk of T2D from the literature. These interactions were not replicated in the EPIC-InterAct study, which mirrored the analyses undertaken in the original reports. Our findings highlight the importance of independent replication of reported interactions.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.4MB, Terms of use)
-
- Publisher copy:
- 10.3945/ajcn.116.150094
Authors
- Publisher:
- American Society for Nutrition
- Journal:
- American Journal of Clinical Nutrition More from this journal
- Volume:
- 106
- Issue:
- 1
- Pages:
- 263-275
- Publication date:
- 2017-06-01
- Acceptance date:
- 2017-04-26
- DOI:
- EISSN:
-
1938-3207
- ISSN:
-
0002-9165
- Pmid:
-
28592605
- Language:
-
English
- Keywords:
-
- Pubs id:
-
pubs:700122
- UUID:
-
uuid:8fc452ec-4eb1-4cac-b05a-8d9fd2cb8cd6
- Local pid:
-
pubs:700122
- Source identifiers:
-
700122
- Deposit date:
-
2017-12-01
Terms of use
- Copyright holder:
- Key et al
- Copyright date:
- 2017
- Notes:
- This is an open access article distributed under the CC-BY license (http://creativecommons.org/licenses/by/3.0/).
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record